US industrial production down 0.5% in April

FILE - In this July 5, 2018, file photo workers assemble the Afloat water mattresses at the factory in Corona, Calif. On Wednesday, May 15, 2019, the Federal Reserve reports on U.S. industrial production for April. (AP Photo/Chris Carlson, File)

WASHINGTON — U.S. industrial production fell in April, dragged by a big drop in factory output as production of autos and auto parts continued to slide.

The Federal Reserve says industrial output — reflecting total production at factories, utilities and mines — dropped 0.5% in April after a 0.2% March gain. Industrial production fell 0.5% in February.

Manufacturing output fell 0.5%, led by a 2.6% decline in motor vehicles and parts, which has fallen in three of the past four months.

Production at the nation's utilities fell a sharp 3.5%. Production at mines, a sector that also covers oil and gas drilling, rose 1.6%.

Manufacturing has struggled over the past year, reflecting weakness in auto sales and the global economy.

You may also interested in

Some vacation spots quietly benefit as travelers avoid Zika

Aug 23, 2016

Zika fears are leading some to book away from the Caribbean and Florida

Tesla lays claim to world's fastest production car

Aug 23, 2016

Tesla Motors says new version of the Model S electric car is now the quickest production car in the world from zero to 60 miles per hour

How EpiPen's maker raised prices, and hackles, so much

Aug 23, 2016

Sky-high price hikes for an emergency allergy medicine are making drugmaker Mylan the latest target for patients and politicians infuriated by soaring drug costs

People also read these

Gap offers muted outlook for annual earnings, lower profit

Aug 18, 2016

Gap offers a downbeat annual profit outlook after reporting a 43 percent drop in net income for the second quarter

Zika researchers seeking volunteers willing to be infected

Aug 19, 2016

Researchers looking for volunteers willing to be infected with the Zika virus as part of effort to develop vaccines

Valeant, attempting to normalize operations, names new CFO

Aug 22, 2016

Valeant Pharmaceuticals is replacing Robert Rosiello as chief financial officer as the embattled pharmaceutical company attempts to normalize operations amid a host of ongoing investigations and class action suits

Emporium Post fulfils the need to know all things about consumers and how businesses can take this opportunity to reach their own customers.

Contact us: sales@emporiumpost.com

Join our mailing list now!